Preclinical pharmacologic studies on 1-nitro-9-(dimethylamino)-acridine and 1-nitro-10-(dimethylaminoethyl)-9-acridone. I. Acute and subacute action.
D000166:Acridines / Q000494:pharmacology / Q000633:toxicity*; D000284:Administration, Oral; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D001921:Brain / Q000187:drug effects; D002021:Buffers; D055598:Chemical Phenomena; D002621:Chemistry; D004123:Dimethylamines / Q000494:pharmacology / Q000633:toxicity; D004353:Drug Evaluation, Preclinical; D005021:Ethylamines / Q000494:pharmacology / Q000633:toxicity; D005260:Female; D006168:Guinea Pigs; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D009130:Muscle, Smooth / Q000187:drug effects; D009574:Nitro Compounds / Q000494:pharmacology / Q000633:toxicity; D011817:Rabbits; D051381:Rats; D012098:Reproduction / Q000187:drug effects; D012119:Respiration / Q000187:drug effects; D013997:Time Factors
D000166:Acridines; D002021:Buffers; D004123:Dimethylamines; D005021:Ethylamines; D009574:Nitro Compounds